Just when you think a stock can never fall again... it usually does.

Anyone who has been watching the semiconductor sector in recent months will know exactly what I'm talking about...

Semiconductor stocks have soared this year. Investors believe we're in the early stages of a multiyear AI-infrastructure build-out rather than a short-lived spending cycle.

You see, the largest tech companies are spending hundreds of billions of dollars building AI data centers, which require tens or even hundreds of thousands of microchips.

And it's not just graphics processing units ("GPUs") in these data centers... It's high-bandwidth memory, networking chips, optical interconnects, and power-management chips.

Almost every part of the semiconductor ecosystem benefits from the AI build-out. Gartner now expects global semiconductor revenue to surpass $1.3 trillion in 2026, up 64% compared with 2025. And AI chips are projected to account for roughly 30% of industry sales.

As a result, investors have been pouring into semiconductors. In fact, semiconductor funds have seen a record $46 billion in inflows this year...

Based on all of this, semiconductor stocks probably seem like the trade of a century. But nothing moves upward in a straight line forever...

Semiconductor stocks have pulled back in recent weeks. In fact, the PHLX Semiconductor Sector Index recently entered bear market territory when it fell more than 20% from its previous high. Take a look...

So folks who bought semiconductor stocks over the past month – thinking they were hopping on a rocket ship to quick profits – are now in the hole.

To be fair, semiconductor stocks may run higher from here over the long term. But I don't think the selling is done yet in the short term.

The reason I say that is because of my new StockTracker tool. My team and I have been developing and perfecting this system for a while now.

It uses relative strength and momentum to anticipate when sectors like utilities, real estate, and communications services – along with individual stocks and industries – are poised to begin outperforming the overall market. And, crucially, it also predicts when market leaders are about to topple...

The State Street SPDR S&P Semiconductor Fund (XSD), which invests in semiconductor stocks in equal weight, hit an all-time high in June. Then, just a few weeks later, XSD went into what I call "bearish" territory in my StockTracker.

If you had used my system at the time, you could've seen the 20%-plus drop in semiconductor stocks coming before it happened... and taken your profits.

And according to StockTracker, XSD is still in bearish territory. My system shows that XSD has a long way to go until it's officially in "bottoming" territory. So we don't think a bottom is in for semiconductor stocks just yet.

It may be weeks or even months before XSD makes it back into my system's "buy zone."

Fortunately, if you have access to StockTracker, you'll know exactly when to get back into the semiconductor trade. That way, you can maximize your gains once the next big rally kicks off.

To hear all the details about my new system and how it works, click here. Today is the last day you can check this out.

What We're Reading...

Here's to our health, wealth, and a great retirement,

Dr. David Eifrig and the Health & Wealth Bulletin Research Team
July 22, 2026

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top